Despite a longstanding effective vaccine and guidelines indicating vaccination for all people living with HIV
People living with HIV have a higher incidence (1.1–1.6 per 100 person-years) of acute hepatitis B infection and a higher prevalence (8–9%) of chronic infection than the general population in the U.S. An effective vaccine for hepatitis B has been available for over 30 years, and the Advisory Committee on Immunization Practices (ACIP) recommends hepatitis B vaccination for HIV-infected people. To determine the percentage of people with HIV who have not been vaccinated, and to describe factors associated with vaccination, investigators from the CDC analyzed data from the Medical Monitoring Project for 2009–2012.
Among 18,089 people in HIV care during the surveillance period (72.4% male; 41.3% non-Hispanic black; 76.4% >40 years of age; 48.2% m…
Reviewing Author
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)
DisclosuresGrant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; NIH/National Institute on Drug Abuse
Editorial BoardsJAIDS: Journal of Acquired Immune Deficiency Syndromes; Vaccines
Leadership Positions in Professional SocietiesInternational Antiviral Society–USA (Board of Directors); Infectious Diseases Society of America (Past President)